Roy D. Baynes
CIK 1680739 · Chief Medical Officer · last filed 2026-05-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.54M
Companies
7
Total Filings
57
Lifetime Open-Market Net
-$11.18M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TVTX | Director | 41,500 | $52.04 | $2.16M | -$2.86M | 12 | 2026-05-21 |
| NRIX | Director | — | $16.95 | — | $0 | 3 | 2026-05-15 |
| NTRA | Director | 18,512 | $212.07 | $3.93M | -$8.32M | 30 | 2026-04-28 |
| EIKN | Chief Medical Officer | — | $8.75 | — | $0 | 1 | 2026-03-04 |
| AARD | Director | — | $3.90 | — | $0 | 1 | 2025-06-13 |
| ATRA | Director | 43,500 | $10.41 | $452.8K | $0 | 5 | 2022-06-27 |
| Travere Therapeutics, Inc. (RTRX) Delisted | Director | 14,000 | — | — | $0 | 5 | 2020-05-19 |
Recent Filings · Page 3 of 6
57 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-23 | TVTX | Mixed | — | -$40.0K | EDGAR |
| 2024-11-15 | NTRA | Mixed | — | -$4.57M | EDGAR |
| 2024-10-29 | NTRA | Grant (A) | +124 | $0 | EDGAR |
| 2024-07-30 | NTRA | Grant (A) | +143 | $0 | EDGAR |
| 2024-07-02 | NTRA | Grant (A) | +2,964 | $0 | EDGAR |
| 2024-05-10 | TVTX | Grant (A) | +6,500 | $0 | EDGAR |
| 2024-04-30 | NTRA | Grant (A) | +169 | $0 | EDGAR |
| 2024-01-30 | NTRA | Grant (A) | +215 | $13.7K | EDGAR |
| 2023-10-31 | NTRA | Grant (A) | +322 | $13.7K | EDGAR |
| 2023-08-01 | NTRA | Grant (A) | +264 | $12.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.